# General Atlantic's Biotech Investments: 20 Startups in Its Portfolio (2026) > The 20 Biotech startups General Atlantic has backed, by stage: $4.7B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/general-atlantic-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 7 - [Ultima Genomics](https://millionrounds.com/company/ultima-genomics) - [Alumis](https://millionrounds.com/company/alumis) - [Nurix Therapeutics](https://millionrounds.com/company/nurix-therapeutics) - [Centessa Pharmaceuticals](https://millionrounds.com/company/centessa-pharmaceuticals) - [*OT* Ocumension Therapeutics](https://millionrounds.com/company/ocumension-therapeutics) - [*RR* Rubicon Research](https://millionrounds.com/company/rubicon-research) - [Third Harmonic Bio](https://millionrounds.com/company/third-harmonic-bio) ## Series C and later 6 - [PathAI](https://millionrounds.com/company/pathai) - [*GB* Gingko Bioworks](https://millionrounds.com/company/gingko-bioworks) - [Sonendo](https://millionrounds.com/company/sonendo) - [Biotheus](https://millionrounds.com/company/biotheus) - [Adagene](https://millionrounds.com/company/adagene) - [Biofourmis](https://millionrounds.com/company/biofourmis) ## Series A 4 - [Verdiva Bio](https://millionrounds.com/company/verdiva-bio) - [*CP* CinCor Pharma](https://millionrounds.com/company/cincor-pharma) - [LifeCare](https://millionrounds.com/company/lifecare) - [Allonnia](https://millionrounds.com/company/allonnia) ## Series B 3 - [Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics) - [Expedition Therapeutics](https://millionrounds.com/company/expedition-therapeutics) - [Pharvaris](https://millionrounds.com/company/pharvaris) ## Segment by segment ### Stage not reported 7 startups · $1.7B raised - [**Ultima Genomics**](https://millionrounds.com/company/ultima-genomics) Ultima Genomics, Inc. United States $600M - [**Alumis**](https://millionrounds.com/company/alumis) Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders. United States $345M - [**Nurix Therapeutics**](https://millionrounds.com/company/nurix-therapeutics) Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs. United States $250M - [**Centessa Pharmaceuticals**](https://millionrounds.com/company/centessa-pharmaceuticals) Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs. United States $250M - [*OT* **Ocumension Therapeutics**](https://millionrounds.com/company/ocumension-therapeutics) Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies. China $164M - [*RR* **Rubicon Research**](https://millionrounds.com/company/rubicon-research) India $100M - [**Third Harmonic Bio**](https://millionrounds.com/company/third-harmonic-bio) Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor. United States $3.9M ### Series C and later 6 startups · $1.1B raised - [**PathAI**](https://millionrounds.com/company/pathai) PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time. United States $400M - [*GB* **Gingko Bioworks**](https://millionrounds.com/company/gingko-bioworks) United States $275M - [**Sonendo**](https://millionrounds.com/company/sonendo) Sonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy. United States $146M - [**Biotheus**](https://millionrounds.com/company/biotheus) Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics. China $115M - [**Adagene**](https://millionrounds.com/company/adagene) Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies. China $83M - [**Biofourmis**](https://millionrounds.com/company/biofourmis) Biofourmis is a global technology-enabled care delivery provider based in Boston, Massachusetts, with additional offices in Singap United States $55M ### Series A 4 startups · $1.0B raised - [**Verdiva Bio**](https://millionrounds.com/company/verdiva-bio) Verdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024. United Kingdom $601M - [*CP* **CinCor Pharma**](https://millionrounds.com/company/cincor-pharma) CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases. United States $275M - [**LifeCare**](https://millionrounds.com/company/lifecare) LifeCare is a privately held company based in Shelton, Connecticut, specializing in employer-sponsored work-life benefits and care solutions. United States $105M - [**Allonnia**](https://millionrounds.com/company/allonnia) Allonnia is a Boston-based bio-ingenuity company founded in 2019, focusing on environmental biotechnology and engineering. United States $20M ### Series B 3 startups · $914M raised - [**Akero Therapeutics**](https://millionrounds.com/company/akero-therapeutics) Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state. United States $502M - [**Expedition Therapeutics**](https://millionrounds.com/company/expedition-therapeutics) Expedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024. United States $280M - [**Pharvaris**](https://millionrounds.com/company/pharvaris) Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients. Switzerland $132M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names General Atlantic as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **General Atlantic's Fintech portfolio** 15 startups · $20B](https://millionrounds.com/portfolio-maps/general-atlantic-fintech-portfolio)[Sector portfolio **General Atlantic's AI portfolio** 12 startups · $171B](https://millionrounds.com/portfolio-maps/general-atlantic-ai-portfolio)[Co-investors **Who invests with General Atlantic** 207 co-investors](https://millionrounds.com/portfolio-maps/general-atlantic-co-investors)[Portfolio map **General Atlantic portfolio map** 108 startups · $217B](https://millionrounds.com/portfolio-maps/general-atlantic-portfolio-map)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio) ## Raising from investors like General Atlantic? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)